Literature DB >> 17265399

Economics and preventing hospital-acquired infection: broadening the perspective.

Nicholas Graves1, Kate Halton, David Lairson.   

Abstract

OBJECTIVE: To present a hypothetical model of the change in economic costs and health benefits to society that result from nosocomial infection control programs.
DESIGN: We use a modeling framework to represent how 2 types of costs change with nosocomial infection control programs: costs incurred by the hospital sector and community health services, as well as the private costs to patients. We also demonstrate how to value the health benefits of nosocomial infection control programs, using quality-adjusted life years.
SETTING: Hypothetical modeling to incorporate the societal perspective.
SUBJECTS: A cohort of 50,000 simulated patients at risk of surgical site infection following total hip replacement. INTERVENTION(S): A total of 8 hypothetical interventions that change costs and health outcomes among the cohort by preventing cases of surgical site infection following total hip replacement. RESULTS AND
CONCLUSIONS: We demonstrate that when infection control interventions reduce economic costs and increase health benefits, they should be adopted without further question. If, however, interventions increase economic costs and increase health benefits, then the trade-off between costs and benefits should be examined. Decision-makers should assess the cost per unit of health benefit from infection control programs, consider the impact on health budgets, and compare infection control with alternative uses of scarce healthcare resources.

Entities:  

Mesh:

Year:  2007        PMID: 17265399     DOI: 10.1086/510787

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  24 in total

1.  The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

2.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

3.  The potential value of Clostridium difficile vaccine: an economic computer simulation model.

Authors:  Bruce Y Lee; Michael J Popovich; Ye Tian; Rachel R Bailey; Paul J Ufberg; Ann E Wiringa; Robert R Muder
Journal:  Vaccine       Date:  2010-06-10       Impact factor: 3.641

4.  Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.

Authors:  Bruce Y Lee; Rachel R Bailey; Kenneth J Smith; Robert R Muder; Elsa S Strotmeyer; G Jonathan Lewis; Paul J Ufberg; Yeohan Song; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

5.  Cost-effectiveness of a central venous catheter care bundle.

Authors:  Kate A Halton; David Cook; David L Paterson; Nasia Safdar; Nicholas Graves
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

6.  Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

Authors:  Bruce Y Lee; Becky Y Tsui; Rachel R Bailey; Kenneth J Smith; Robert R Muder; G Jonathan Lewis; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

Review 7.  Cost-effectiveness of interventions to reduce the risk of healthcare-acquired infections in middle-income countries: A systematic review.

Authors:  Pushpa Udayangani Gamalathge; Sanjeewa Kularatna; Hannah E Carter; Sameera Senanayake; Nicholous Graves
Journal:  J Infect Prev       Date:  2019-06-04

8.  Costs of surgical site infections that appear after hospital discharge.

Authors:  Nicholas Graves; Kate Halton; Merrilyn Curtis; Shane Doidge; David Lairson; Marylou McLaws; Michael Whitby
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

9.  Antimicrobial catheters in the ICU: is the juice worth the squeeze?

Authors:  Nasia Safdar
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

10.  Oral versus IV treatment for catheter-related bloodstream infections.

Authors:  Burke A Cunha
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.